中文 | English
Return
Total: 35 , 1/4
Show Home Prev Next End page: GO
MeSH:(Cholangiocarcinoma/metabolism/*pathology)

1.Correlation between clinicopathological features and CA19-9/CEA in patients with extrahepatic cholangiocarcinoma.

Xiaolong TANG ; Jianwei ZHANG ; Yingtai CHEN ; Zhongmin LAN ; Chengfeng WANG

Chinese Journal of Oncology 2014;36(9):662-666

5.Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases.

Jing XU ; Cuiming ZHANG ; Aixiu QIAO ; Yanfeng XI

Chinese Journal of Pathology 2016;45(3):175-179

6.Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma.

Shi-mei ZHAO ; Xiong-zeng ZHU ; Yuan JI ; Jun HOU

Chinese Journal of Pathology 2008;37(11):749-753

8.Expression of WW domain containing oxidoreductase gene in cholangiocarcinoma and its effect on the biological behavior of cancer cell line RBE.

Qiang HUANG ; Kai ZHU ; Chen-hai LIU ; Fang XIE ; Peng XU ; Zhi-gang TANG

Chinese Journal of Surgery 2011;49(4):324-329

9.Effect of hepatitis C virus core protein on cholangiocarcinoma tissues' epithelial-mesenchymal transition.

Tian-yu LI ; Shu-guang WANG ; Da-jiang LI ; Zhan-feng GAO ; Ying-hong GAO ; Wei-wei JIANG

Chinese Journal of Surgery 2007;45(21):1491-1493

10.Clinicopathologic features of combined hepatic carcinoma.

Cai HE ; Hong-fang YIN ; Ping LIU ; Ying ZHANG ; Jian-bo ZHANG

Chinese Journal of Pathology 2013;42(12):824-828

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 35 , 1/4 Show Home Prev Next End page: GO